A large clinical trial suggests that a daily multivitamin may influence the pace at which the body ages. Researchers led by Mass General Brigham report that older adults who took a daily multivitamin ...
Self-examination behavior varied markedly: roughly 20% reported none in the prior year, while about one-third examined weekly ...
A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...
The 2026 European Association of Urology (EAU) annual meeting featured a late-breaking abstracts session and a presentation ...
Apixaban halved the risk for bleeding compared with rivaroxaban in the treatment of acute venous thromboembolism in the ...
A randomized phase 2 peri-operative (neoadjuvant plus adjuvant) study of fianlimab (anti–LAG-3) plus cemiplimab (anti–PD-1) versus anti–PD-1 alone in patients with resectable stage III and IV melanoma ...
Initial treatments are underway in randomized study of Acorn’s personalized autologous injectable for improving facial ...
Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results